Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel agents for urinary incontinence covered by Boehringer Ingelheim patent

Oct. 15, 2002

Merck patent covers novel alpha1A-adrenoceptor antagonists and their use in BPH

Oct. 14, 2002

Dutasteride approved for launch as first dual-acting 5alpha-reductase inhibitor for BPH

Oct. 11, 2002

Novel small-molecule leads targeting the V2 vasopressin receptor

Oct. 11, 2002

Reduction of RCN incidence with fenoldopam mesilate after contrast angiography

Oct. 10, 2002

Keryx extends manufacturing and negotiating rights for KRX-101

Oct. 8, 2002

Positive clinical results for PT-141 in moderate to severe MED

Oct. 4, 2002

GPI-1485 shows neuroprotective activity in preclinical models of postprostatectomy ED

Oct. 1, 2002

Vardenafil: phase III clinical data discussed at congress, trade name selected

Sep. 27, 2002

Trospium meets endpoints in phase III overactive bladder trial

Sep. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...